These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 8876780)
21. Statin therapy in the treatment of Alzheimer disease: what is the rationale? DeKosky ST Am J Med; 2005 Dec; 118 Suppl 12A():48-53. PubMed ID: 16356808 [TBL] [Abstract][Full Text] [Related]
22. Can phenytoin prevent Alzheimer's disease? Dhikav V Med Hypotheses; 2006; 67(4):725-8. PubMed ID: 16781825 [TBL] [Abstract][Full Text] [Related]
25. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y Neurology; 2006 Sep; 67(6):998-1005. PubMed ID: 16914696 [TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
27. Can herbs provide a new generation of drugs for treating Alzheimer's disease? Anekonda TS; Reddy PH Brain Res Brain Res Rev; 2005 Dec; 50(2):361-76. PubMed ID: 16263176 [TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC; Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497 [TBL] [Abstract][Full Text] [Related]
30. Primary prevention trials in Alzheimer disease. Green RC; DeKosky ST Neurology; 2006 Nov; 67(9 Suppl 3):S2-5. PubMed ID: 17101930 [TBL] [Abstract][Full Text] [Related]
31. Community engagement in diverse populations for Alzheimer disease prevention trials. Romero HR; Welsh-Bohmer KA; Gwyther LP; Edmonds HL; Plassman BL; Germain CM; McCart M; Hayden KM; Pieper C; Roses AD Alzheimer Dis Assoc Disord; 2014; 28(3):269-74. PubMed ID: 24614272 [TBL] [Abstract][Full Text] [Related]
32. Fisher symposium: strategies for the prevention of Alzheimer disease--overview of research planning meeting III. Radebaugh TS; Buckholtz NS; Khachaturian ZS Alzheimer Dis Assoc Disord; 1996; 10 Suppl 1():1-5. PubMed ID: 8876779 [TBL] [Abstract][Full Text] [Related]
33. The long and winding road Toward Alzheimer prevention FDA offers new guidance on developing drugs for early-stage AD; seeks input. Ott BR R I Med J (2013); 2013 Apr; 96(4):14-5. PubMed ID: 23641444 [No Abstract] [Full Text] [Related]
34. Statistical issues in prevention and therapeutic trials of Alzheimer disease. Brookmeyer R; Zeger S Alzheimer Dis Assoc Disord; 1996; 10 Suppl 1():27-30. PubMed ID: 8876786 [TBL] [Abstract][Full Text] [Related]
35. Prevention of Alzheimer disease: a perspective based on successes in the prevention of other chronic diseases. Larson EB; Kukull WA Alzheimer Dis Assoc Disord; 1996; 10 Suppl 1():9-12. PubMed ID: 8876781 [TBL] [Abstract][Full Text] [Related]
36. Approaches to the prevention of Alzheimer disease. Scherr PA Alzheimer Dis Assoc Disord; 1996; 10 Suppl 1():17-8. PubMed ID: 8876783 [TBL] [Abstract][Full Text] [Related]
37. Steroid therapy in AD. Gambassi G; Landi F; Bernabei R Neurology; 1997 May; 48(5):1473-4. PubMed ID: 9153504 [No Abstract] [Full Text] [Related]
38. [Preservation of health]. Sasaki H; Fujii M; Ishizuka S; Azumi M Nihon Ronen Igakkai Zasshi; 2010; 47(6):511-6. PubMed ID: 21301139 [No Abstract] [Full Text] [Related]